Cargando…
From “Glivec(®)” to “Prevnar 13(®)”: How strong is the Indian drug patenting system?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176695/ https://www.ncbi.nlm.nih.gov/pubmed/30319951 http://dx.doi.org/10.4103/picr.PICR_102_18 |